Cito Capital Group, LLC Pfizer Inc Transaction History

Cito Capital Group, LLC

$258 Million
Q2 2024

A detailed history of Cito Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cito Capital Group, LLC holds 56,750 shares of PFE stock, worth $1.59 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

56,750

Previous 42,250 34.32%

Holding current value

$1.59 Million

Previous $1.17 Million 35.49%

% of portfolio

0.62%

Previous 0.48%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $366,270 - $429,200	14,500 Added 34.32%	56,750 $1.59 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $25,890 - $29,730	1,000 Added 2.42%	42,250 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $19,597 - $25,455	750 Added 1.85%	41,250 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $48,135 - $56,265	1,500 Added 3.85%	40,500 $1.34 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $236,340 - $307,680	6,000 Added 18.18%	39,000 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $232,650 - $275,850	-5,000 Reduced 13.16%	33,000 $1.73 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $266,768 - $330,559	-5,831 Reduced 13.3%	38,000 $1.97 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $196,250 - $252,100	5,000 Added 12.88%	43,831 $1.89 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $485,605 - $547,665	14,500 Added 59.59%	38,831 $1.41 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $22,138 - $26,856	735 Added 3.11%	24,331 $796,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $20,677 - $29,544	765 Added 3.35%	23,596 $770,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $707,761 - $779,678	22,831	22,831 $0

Others Institutions Holding PFE

# of Institutions

3,247

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.

Account

Cito Capital Group, LLC Pfizer Inc Transaction History